Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Entera Bio Ltd (NQ: ENTX )

1.690 USD -0.070 (-3.98%)
Official Closing Price Updated: 7:50 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 302,500
Open 1.760
Bid (Size) 1.700 (25)
Ask (Size) 1.750 (3)
Prev. Close 1.760
Today's Range 1.660 - 1.760
52wk Range 1.000 - 3.400
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Entera Bio Issues Letter to Shareholders
From GlobeNewswire News Releases
Entera Bio Announces FDA Approval of IND Application for EB613 – an Oral Human Parathyroid Hormone (1-34) for the Treatment of Osteoporosis
EB613 Phase 2 Placebo-Controlled, Dose-Ranging Study Ongoing in Israel with Complete 3 Month Biomarker Data expected in Q1:21 and Final Bone Mineral Density, or BMD, Data Expected in Q2:21 
From GlobeNewswire News Releases

Performance

YTD
+36.29%
+36.29%
1 Month
+57.94%
+57.94%
3 Month
+50.22%
+50.22%
6 Month
-6.11%
-6.11%
1 Year
-46.38%
-46.38%

More News

Read More
Entera Bio Appoints Spiros Jamas as Chief Executive Officer
From GlobeNewswire News Releases
Entera Bio Ltd Announces Third Quarter 2020 Financial Results and Provides Clinical Update
From GlobeNewswire News Releases
Entera Bio to Report Third Quarter 2020 Business and Financial Results on November 19, 2020
From GlobeNewswire News Releases
Entera Bio Ltd Announces Completion of Enrollment In Phase 2 Clinical Trial of Eb613 In Osteoporosis
From GlobeNewswire News Releases
Entera Bio to Present at the H.C. Wainwright 6th Annual Israel Conference
From GlobeNewswire News Releases
Entera Bio to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
From GlobeNewswire News Releases
Entera Bio Ltd Announces Interim Data From Phase 2 Clinical Trial of EB613 in Osteoporosis and Second Quarter 2020 Financial Results
From GlobeNewswire News Releases
12 Healthcare Stocks Moving In Wednesday's Pre-Market Session
Tags Benzinga Movers EYPT
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
Tags Intraday Update NTUS Trading Ideas
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.